NOV 28, 2015 6:44 AM PST

Rare Tropical Disease Puts Transplant Patients At Risk

WRITTEN BY: Kara Marker
Leishmaniasis is an infectious disease caused by the bite of parasite-infected sand flies, and it's usually found in tropical regions and southern Europe. The infection can be either cutaneous, causing skin sores, or visceral, affecting internal organs (CDC). The number of leishmaniasis infections has quadrupled since the 1990s, and researchers from Spain looked to calculate the risk and determine how to prevent infections in vulnerable transplant patients. 
 Geographical distribution of visceral leishmaniasis

In a recent study published in PLoS Neglected Tropical Diseases, scientists looked at 63 individuals who had received solid organ transplants and worked to determine the number of patients who had come into contact with the parasite and what their risk was of developing leishmaniasis at any point for the rest of their lives. Because of the immunosuppressive therapy transplant patients receive to prevent organ rejection, these patients have a 100 times greater risk of developing severe visceral leishmaniasis compared to immunocompetent people.

The team conducted two tests scanning for any form of leishmaniasis infection. One test involved experimental lymphocyte proliferation assays and cytokine production analysis, to examine how the immune system was working, potentially hinting at a leishmaniasis invasion. The second test was more routine - "serologic and parasitology tests" that are normally used to diagnose cases of leishmaniasis. 

The scientists saw a correlation between the two tests, and this initial success points to the experimental assays as new indicators of leishmaniasis progression at various stages of infection. Continuing studies with these analytic tests could help scientists understand the relationship between transplant patients and their lifetime risk of developing leishmaniasis. 

Ultimately, the team is interested in preventing the initial transmission of leishmaniasis as well as relapse recovery. Identifying which immunocompromised patients are at high risk of relapsing with infection could help doctors know when to administer additional chemotherapeutics to prevent additional infections in individuals not completely recovered. 

"Being the recipient of an organ tranplant is increasingly common amoung the Spanish population," said Dr. Javier Moreno, team researcher. "As a consequence, it is necessary to both prevent the risk of infection in transplant patients and to adopt appropriate measures for disease management and prevention in clinical cases in order to prevent relapses."

Watch the following video to learn more about leishmaniasis. 

Source: Plataforma SINC
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 15, 2020
Immunology
Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow
SEP 15, 2020
Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow
A therapeutic made from turmeric has been shown to help reduce the effects of a painful inflammatory eye condition in do ...
SEP 24, 2020
Immunology
Remember That Coronavirus You Once Met? Your T Cells Do.
SEP 24, 2020
Remember That Coronavirus You Once Met? Your T Cells Do.
The SARS-CoV-2 virus was first identified in December 2019 in Wuhan, Hubei, China and quickly escalated to a pandemic st ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 13, 2020
Immunology
Why Halloween Is Extra Scary for Kids With Peanut Allergies
OCT 13, 2020
Why Halloween Is Extra Scary for Kids With Peanut Allergies
A recent study showed that there is an 85 percent spike in peanut allergy anaphylaxis cases on Halloween. The study, per ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
OCT 20, 2020
Immunology
The Immune Pause Button Slowing MS Progression
OCT 20, 2020
The Immune Pause Button Slowing MS Progression
  Scientists have a new theory about the genetics behind the progressive, debilitating effects of multiple sclerosi ...
Loading Comments...